Home
Technologies
Indications
Pipeline
News
Home
Technologies
Indications
Pipeline
News
Home
Technologies
Indications
Pipeline
News
Research
How we choose
Type 2 Diabetes
In vitro & In vivo
Genital Herpes
In vitro & In vivo
Endometriosis
In vitro & In vivo
HIV Prophylaxis
In vitro & In vivo
Other Indications
In vitro & In vivo
Technology
Technology Platforms
Versa
Exenatide Intravaginal ring
Leuprolide Intravaginal ring
Acyclovir Intravaginal ring
HIV prophylaxis Intravaginal ring
Vitrsert® and Retisert ®
Other Technologies
Codrug
How it works
Plexis
How it Works
Particle Size
Membrane Based Delivery
Indications
Graft Rejection
Schizophrenia
HIV/AIDS
Parkinson's Disease
Arthritis
Macular Edema
News
Press Releases
Enrollment completed for Tacrolimus Clinical Trial
Auritec Announces Judgement against Oak Crest
Arthritis Press Release 2016
Automation Ring Manufacture
NIH Grants Clinical Trial Funding
Tacrolimus IND Approved by FDA
Triple Ring IND Approved by FDA
New Manufacturing Facility 2011
HIV Ring Manufacture 2011
Auritec Completes First Clinical Trial 2011
Tenofovir Ring Press Release 2009
CONRAD funds Microbicide Collaboration 2009
Microbicide Collaboration with OCIS 2008
O-Ray Spin off for Ear Indications 2005
Company
Home
Hidden
Mail
Mail
© Copyright 2016 Auritec Pharmaceuticals Inc. All Rights Reserved.